Psychosis Precipitated by Acetyl-l-Carnitine in a research subjects With Bipolar Disorder [PMID: 17599177] Laboratory literature summary: Psychosis Precipitated by Acetyl-l-Carnitine in a research subjects With Bipolar Disorder
The peptide's safety profile appears favorable with minimal reported side effects, making it an attractive option for fibromyalgia patients seeking alternatives to conventional pain medications
doi: 10.3389/fendo.2023.1085799 Received 31 October 2022 Accepted 02 January 2023 Published 01 February 2023 Volume 14 - 2023 Edited by Xiaodong Sun, Affiliated Hospital of Weifang Medical University, China Reviewed by Kefei Dou, Chinese Academy of Medical Sciences and Peking Union Medical College, China
alternative-therapies.com No large scale blinded dose ranging Phase II or efficacy Phase III RCTs have been published, and no comprehensive peer reviewed human pharmacokinetic (PK) profile (oral vs injection absorption, bioavailability, distribution, metabolism, excretion) is available